Publications by authors named "A V Goncharenko"
Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disorder characterized by a combination of main symptoms: opsoclonus, myoclonus, ataxia, psychoemotional and behavioral disturbances. OMS can develop in children as a result of immunopathological processes against the background of infectious or oncological pathology and lead to persistent neurological deficit. A case of ten-year observation of paraneoplastic OMS associated with neuroblastoma in a child is presented.
View Article and Find Full Text PDFArticle Synopsis
- Multidrug-resistant strains, particularly those linked to farm animals, are a growing concern for human health due to their ability to cause severe intestinal and extraintestinal diseases.
- This study focuses on APEC 36, a strain isolated from a chicken with a serious infection, analyzing its genome and finding it has multiple antibiotic resistance mechanisms, mainly antibiotic efflux.
- APEC 36 also contains unique genetic traits, such as a rare beta-lactamase variant and genes linked to toxins and iron uptake, indicating that it could pose significant threats to human health.
The physics of nonlinear optical materials is incredibly versatile, with the design of novel materials and structures offering numerous degrees of freedom. Nevertheless, weak inherent nonlinearity of conventional optical materials continues to hinder the progress of a number of important applications. In this study, we delve into the realm of broadband enhancement of nonlinearity within one-dimensional (1d) plasmonic metamaterials, exploring its intricate connection with nonlocality.
View Article and Find Full Text PDFToxin-antitoxin (TA) systems are widely present in bacterial genomes. , a common model organism for studying physiology, has eight TA loci, including and . This study aims to investigate the physiological significance of these TA systems.
View Article and Find Full Text PDF2-Ethyl-6-methyl-3-hydroxypyridine succinate (EMHPS, Mexidol) is an original antioxidant and an anti-ischemic drug with the possibility of wide applications in the complex therapy of diseases, accompanied by the development of oxidative stress and ischemia; for example, ischemic stroke, chronic cerebral ischemia, and chronic heart failure. The use of EMHPS in the complex therapy of the above diseases may cause the development of drug-drug interactions, particularly pharmacokinetic interactions at the level of transporter proteins. In the present study, we evaluated the interaction of EMHPS with ABCB1 and SLCO1B1.
View Article and Find Full Text PDF